CCL2 is overexpressed in various cancers and is associated with poor prognosis in breast, colorectal, and thyroid cancers [28], and a lack of CCL2 is associated with increased survival in patients with cervical cancer [29]. This evidence concerns the gene CCL2 and thyroid gland carcinoma.